Despite observations that the lacrimal gland has been identified as the principal source of dimeric immunoglobulin A (dIgA) in tears, the mechanism used by lacrimal gland acinar cells (LGACs) to transcytose dIgA produced by interstitial plasma cells is not wellcharacterized. This study identifies a transcytotic pathway in LGACs regulated by Rab11a for polymeric immunoglobulin receptor (pIgR) and dIgA. EGFP-tagged Rab11a expressed in primary LGACs labeled a unique membrane compartment of comparable localization to endogenous Rab11a beneath the apical plasma membrane. This compartment was enriched in pIgR and clearly distinct from the regulated secretory pathway. Comparison of dIgA uptake in LGACs expressing wild type and dominant negative EGFPRab11a showed that the rapid exocytosis of dIgA was inhibited in acini expressing the dominant-negative protein, which additionally redistributed subapical pIgR. The trafficking of EGFP-Rab11a-enriched vesicles was regulated by microtubule-based and myosin Vb motors at distinct steps. Our data suggest that Rab11a is a crucial regulator of dIgA trafficking in primary acinar secretory epithelial cells and further support a role for microtubules, cytoplasmic dynein, actin filaments and myosin Vb in the maintenance of the Rab11a compartment in this primary secretory epithelial cell.
Introduction
Lacrimal gland acinar cells (LGACs) are epithelial cells specialized for production, packaging and regulated secretion of diverse tear proteins. In addition to secreting proteins packaged into secretory vesicles, they also use transcytotic mechanisms to transfer key proteins, such as dimeric immunoglobulin A (dIgA), into the tear fluid. dIgA comprises two complete IgA proteins coupled by the J chain and synthesized by plasma cells in the lacrimal gland interstitial space (Walcott, 1998) . dIgA is abundant in tear fluid as secretory IgA (sIgA), i.e. dIgA associated with the secretory component (SC) (Wu et al., 2006) . sIgA in tears produced by the lacrimal gland is the predominant antibody, protecting the ocular surface against antigenic challenge (Gudmundsson et al., 1985; Allansmith et al., 1987) , and is a crucial element of mucosal immunity (Allansmith et al., 1987; Childers et al., 1989; Corthesy and Kraehenbuhl, 1999) . Despite its central role in lacrimal gland and ocular surface physiology, the transcytotic mechanism that transfers sIgA into the tears remains poorly understood.
sIgA release into mucosal fluids depends on the polymeric immunoglobulin A receptor (pIgR) (Childers et al., 1989; Mostov et al., 1995; Corthesy and Kraehenbuhl, 1999; Rojas and Apodaca, 2002) . In transfected Madin-Darby canine kidney (MDCK) cells, pIgR appears to traffic from the trans-Golgi network to the basolateral plasma membrane. With or without its bound ligand, pIgR is endocytosed from the basolateral surface and transported through a series of endosomal compartments to the apical surface (Apodaca et al., 1994; Barroso and Sztul, 1994; Mostov et al., 1995) . At the apical surface, the pIgR extracellular domain is proteolytically cleaved and released as either SC bound to dIgA or as free SC. However, MDCK cells do not express pIgR without transfection, nor do they secrete other proteins through either transcytotic pathways or regulated exocrine pathways equivalent to those expressed in exocrine acinar cells. Therefore, primary LGAC represents a valuable model for studying the function of Rab11a in regulating transcytotic mechanisms in specialized exocrine secretory cells that are also robustly engaged in transcytosis of key mucosal defense proteins.
The lacrimal gland serves as the main source of tear sIgA and SC (Gudmundsson et al., 1985) . It has been shown that, unusually, LGACs divert some fraction of their pIgR internally to generate free SC, which is stored in and released from a pool of exocrine secretory vesicles in the apical cytoplasm (Evans et al., 2008) .
LGACs also respond to secretagogue stimulation by increasing SC secretion through exocytotic and transcytotic mechanisms (Evans et al., 2008) . The relationship between these unique release pathways for SC, and the fundamental transcytotic pathway that is responsible for binding interstitial dIgA and excreting sIgA at the lumen is, however, unknown in these cells.
Rab proteins, which constitute the largest family of small monomeric GTPases, participate in intracellular trafficking by recruiting membrane-tethering and docking factors (Pfeffer, 2001) . Rab GTPases cycle between active GTP-bound and inactive GDP-bound forms, in order to carrying out their functions (Schwartz et al., 2008) . Such cycling is regulated by Rab-GDP-dissociation inhibitors (GDIs) (Shisheva et al., 1999) , Rab-GTPase-activiting proteins (GAPs), and Rab-GTP exchange factors (GEFs) (van de Graaf et al., 2006) , and it is possible to use single amino acid substitutions to generate mutant Rab proteins that are locked in the GTP-bound or GDP-bound state.
The Rab11 GTPases have two isoforms Rab11a and Rab11b, both of which are ubiquitously expressed in mammalian cells (Lapierre et al., 2003) . Although 90% of their amino acid sequence is identical, they show crucial differences in their crystal structure (Scapin et al., 2006) and localize to different compartments in MDCK and gastric parietal cells (Lapierre et al., 2003) . Rab11a is thought to participate in the basolateral-to-apical transcytosis of pIgR and dIgA in transfected MDCK cells that express pIgR, because S25N-mutant GDP-locked dominant-negative (DN) Rab11a mutant (Rab11a DN) strongly inhibits this process (Wang et al., 2000) . However, Rab11a also appears to be involved in regulated exocrine secretory processes in specialized epithelial cells. In bladder umbrella cells, Rab11a is associated with discoidal/fusiform exocytotic vesicles, and expression of Rab11a DN inhibits the regulated secretion from these vesicles (Khandelwal et al., 2008) .
Although the primary aim of this study was to characterize the Rab11a compartment in LGACs and to determine whether it participates in transcytosis and/or exocytosis, we also wanted to determine whether cytoskeletal filaments and their associated motors are involved in Rab11a-enriched vesicle trafficking. Yeast two-hybrid analysis has demonstrated that the tail region of the myosin Vb motor directly interacts with Rab11-FIP2, a downstream effector of Rab11a (Lapierre et al., 2001; Hales et al., 2002) . Yeast two-hybrid analysis also showed that Rab11a wild type (WT) interacted with the myosin Vb tail, whereas Rab11a DN did not (Lapierre et al., 2001) . Moreover, expression of the Myosin Vb tail inhibited basolateral-to-apical transcytosis of dIgA in MDCK cells, trapping dIgA intracellularly (Lapierre et al., 2001 ). Rab11a and myosin Vb proved to be essential for the formation of the bile canaliculus in WIF-B9 cells (Wakabayashi et al., 2005) and for the recycling of the M4 muscarinic acetylcholine receptor in PC12 cells (Volpicelli et al., 2002) .
There is also evidence that Rab11a-enriched compartments interact with microtubules (MTs). In WIF-B9 cells, Rab11a is associated with an endosomal complex that trafficks on MTs but can not traverse the pericanalicular actin and fuse with the canalicular membrane (Wakabayashi et al., 2005) . On the basis of these observations, we hypothesized that both myosin Vb and the MT array participate in the trafficking of Rab11a-enriched vesicles in LGACs.
Our study demonstrates that, in the acinar secretory cell, Rab11a participates in the constitutive transcytotic pathway, which is distinct from the regulated secretory and lysosomal pathways. We find no evidence for the involvement of Rab11a in regulated exocytosis, which is in contrast to research carried out in bladder epithelial cells (Khandelwal et al., 2008) and HClsecreting gastric parietal cells (Duman et al., 1999) . Our findings also confirm, in primary cells engaged functionally in transcytosis of dIgA to a mucosal surface, that Rab11a plays an important role in the mucosal immune system.
Results

Endogenous Rab11a in primary LGACs
Expression of endogenous Rab11a in LGACs was confirmed by western blotting and immunofluorescence. Membrane compartments and cytosol from primary LGAC homogenate were separated by high-speed centrifugation. Endogenous Rab11 isoforms reside primarily in membrane compartments rather than in cytosol [ Fig. 1A , see bands labelled Pi (membrane compartments; pellet) and Si (cytosol; supernatant)]. As an integral membrane protein with a single transmembrane domain, pIgR was also enriched in the Pi fraction.
Isolated primary LGACs were cultured to form spherical or ovoid clusters by the second day of culture, mimicking the acinar-like structures present in situ in the lacrimal gland. The lumenal cavity or cavities located in the center of these acinarlike structures typically have accessible opening(s) to the external space. Individual acinar cells establish histiotypic polarity during the process of reforming the acinar-like structures: apical plasma membranes surround the lumena, whereas the basolateral plasma membranes face the culture medium and adjacent cells (Fig. 1B) . Fluorophore-conjugated phalloidin, which labels F-actin, delineates the dense cortical actin meshwork underlying the apical plasma membrane, outlining the position of the lumen, and the less dense cortical actin meshwork underlying the basolateral membranes (Wang et al., 2003; Evans et al., 2008) . Images taken from a single confocal plane within the reconstituted acinus reveal lumena, apical plasma membranes and basolateral membranes as shown in the schematic (Fig. 1B) .
Confocal fluorescence microscopy of LGACs labeled with antibodies to Rab11a and pIgR showed that endogenous Rab11a was enriched in the subapical region beneath the apical membrane and that it also colocalized with pIgR ( Fig. 1C) , suggesting an association of Rab11a with pIgR-containing membranes in
LGACs. By contrast, confocal microscopy did not show extensive colocalization of Rab11b with pIgR (supplementary material Fig. S1 ). This suggests that Rab11b is associated with a different membrane compartment than Rab11a and that this compartment is probably not involved in pIgR transcytosis.
Overexpression of EGFP-Rab11a in primary LGACs
Adenovirus (Ad) EGFP-Rab11a WT, dominant-negative EGFPRab11a (Ad EGFP-Rab11a DN) and EGFP (Ad EGFP) constructs are all capable of efficiently transducing rabbit primary LGACs. After doxycycline induction, the expression of these recombinant proteins was verified by western blotting using both anti-Rab11 and anti-GFP antibodies (Fig. 1E) . The expression levels of the fusion proteins were on average 13-fold higher than that of the endogenous Rab11 (shown in the same lane). The direct fluorescence of exogenously expressed EGFP-Rab11a in LGACs was also analyzed by confocal microscopy. EGFP-Rab11a-enriched vesicles were mostly localized to the subapical cytoplasm, beneath the apical/luminal plasma membrane. The localization pattern of EGFP-Rab11a was the same as that of endogenous Rab11a (Fig. 1C,D) , suggesting that the overexpression of EGFP-Rab11a does not affect its localization relative to that of endogenous Rab11a. Live cell imaging revealed rapid, directed movement of small EGFPRab11a-enriched apical vesicles, as well as tubules extending between the apical and basolateral domains of the cell. Thus, we hypothesized that the apical vesicle pool participates in pIgR transcytosis (see Movie 1 in supplementary material).
EGFP-Rab11a is not extensively colocalized with early endosomes or lysosomes
We took several approaches to verify the compartmental identity of the EGFP-Rab11a-enriched vesicles in LGACs. Tetramethylrhodamine (TMR)-dextran (MW 70,000) was used as a marker for fluid-phase endocytosis in live LGACs. EGFPRab11a-enriched vesicles did not appear to be accessible to TMR-dextran ( Fig. 2A) . This result suggests that the Rab11a vesicle pool is not accessible to all endocytosed cargo or even to the bulk-endocytosed fluid-phase cargo. EGFP-Rab11a-enriched vesicles were clearly distinct from EEA1-enriched early endosomes, which are large organelles (0.2,1 mm) that exist in both the subapical and basolateral regions of LGACs (Fig. 2B) . Lysotracker Red DND-99 was used as a marker for the acidic lysosomes in live LGACs. EGFP-Rab11a-enriched vesicles clearly did not colocalize with lysosomes ( Fig. 2A) , indicating that they are also distinct from the lysosomal pathway.
Rab11a-enriched vesicles are distinct from the regulated secretory pathway Rab27b has been identified as a marker of subapical secretory vesicles in LGACs (Chiang et al., 2011) . In live LGACs, YFPRab27b labeled large secretory vesicles (,0.5 mm) that mainly resided in the subapical domain (Fig. 3A) , whereas EGFPRab11a labeled a population of much smaller subapical vesicles in the same region (Fig. 3C ). Higher resolution images showed that YFP-Rab27b and EGFP-Rab11a labeled two vesicle pools that appeared to exist in close spatial proximity but did not significantly overlap (Fig. 3C) . Moreover, the co-expression of EGFP-Rab11a WT, EGFP-Rab11a DN or EGFP did not alter the localization of YFP-Rab27b-enriched secretory vesicles (Fig. 3A ,B,C,D).
Rab3D has been identified as another marker for secretory vesicles in LGACs (Evans et al., 2008) that is significantly colocalized with Rab27b (Chiang et al., 2011) . Whereas some Rab3D-enriched secretory vesicles resided in the subapical domain, they were also detected extending into the central domain of the cell (supplementary material Fig. S2A ). EGFPRab11a and Rab3D showed partial colocalization, but they had quite different distribution patterns. Similar to the case of YFPRab27b-enriched vesicles, the co-expression of EGFP-Rab11a WT or EGFP-Rab11a DN (supplementary material Fig. S2A -C) or EGFP (data not shown) did not seem to alter the localization of Rab3D-enriched secretory vesicles.
Carbachol (CCh) is a cholinergic agonist that accelerates the fusion of Rab27b-enriched vesicles, as well as Rab3D-enriched vesicles with the apical plasma membrane in acinar cells (Chen et al., 2004; Imai et al., 2004; Evans et al., 2008) . Confocal fluorescence (A) Cell lysate was fractionated as described in Materials and Methods. The lysate, and the supernatant (Si) and pellet (Pi) fractions were analyzed by western blotting using primary mouse anti-Rab11, mouse anti-actin antibodies and sheep anti-pIgR serum, as well as secondary IRDye 700 goat antimouse antibody and Alexa-Fluor-680-conjugated donkey antisheep antibody. (B) Schematic of acinar-like structures formed by primary LGACs. Left: 3D structure, Right: 2D cross-section of the 3D structure, representing the confocal plane from which the microscopic images were taken. APM, apical membrane; BLM, basolateral membrane; CJ, cell junction; L, lumen. (C) LGACs were fixed, permeabilized and labeled with primary rabbit anti-Rab11a and sheep anti-pIgR serum, as well as secondary FITC-conjugated donkey antirabbit, Alexa-Fluor-568-conjugated donkey anti-sheep antibodies and Alexa-Fluor-647-conjugated phalloidin. Immunofluorescence was observed by confocal microscopy to localize Rab11a (green) and pIgR (red) in LGACs. (D) LGACs were co-transduced with the regulatory virus and EGFP-Rab11a WT, exposed to doxycycline, and fixed and labeled with Alexa-Fluor-647-conjugated phalloidin prior to imaging. (E) LGACs were co-transduced with EGFP-Rab11a WT (lanes 1), EGFP-Rab11a DN (lanes 2) and the regulatory virus. Non-transduced LGACs were used as a control (lanes 3). After induction with doxycycline, the cells were lysed with SDS-PAGE sample buffer, resolved by 10% SDS-PAGE and analyzed by western blotting using primary mouse anti-Rab11 (a) and anti-GFP (b) antibodies, as well as secondary IRDye700-conjugated goat anti-mouse antibody. The signal intensity was quantified with the Odyssey 1.1 software. The schematic images in C and D show the location of apical membrane (APM), basal membrane (BLM) and the lumena (L). *, lumena; scale bar: 5 mm. LGACs expressing EGFP-Rab11a were fixed, permeabilized and labeled with primary goat anti-EEA1 antibodies, secondary Alexa-Fluor-568-conjugated donkey anti-sheep antibody andAlexa-Fluor-647-conjugated phalloidin. *, lumena; scale bar: 5 mm. microscopy analysis showed that a 15-minute treatment with 100 mM CCh did not induce significant changes in the distribution or the dynamics of EGFP-Rab11a-enriched vesicles in LGACs (see Movie 2 in supplementary material), or reveal the characteristic invaginations of fluorescence-labeled apical membrane that is characteristic of fusion of fluorescence-labeled secretory vesicles. By contrast, a 15-minute treatment with 100 mM CCh substantially accelerated the fusion of secretory vesicles labeled by YFP-Rab27b compared with the resting stage (see Movie 3 and Fig. S4 in supplementary material). The lack of extensive colocalization between EGFP-Rab11a and either YFP-Rab27b or Rab3D combined with the lack of responsiveness to CCh suggests that EGFP-Rab11a is not primarily associated with secretory vesicles in the subapical region of the cell.
The regulated secretory pathway in primary LGACs can be stimulated by CCh (Jerdeva et al., 2005; Evans et al., 2008) , and b-hexosaminidase has been identified as a marker of the secretory function in primary LGACs (Andersson et al., 2006) . Therefore, the secretion of b-hexosaminidase and total protein by LGACs were both measured as an additional mechanism to determine the potential impact of the expression of Rab11a constructs on secretory vesicle function. The LGACs expressing EGFP-Rab11a WT, EGFP-Rab11a DN or EGFP showed no significant differences in the secretion of b-hexosaminidase or total protein either at the resting stage or under CCh stimulation (supplementary material Fig. S3A,B ). This result indicated that the expression of EGFP-Rab11a WT or EGFP-Rab11a DN did not significantly alter the regulated secretory function in LGACs, and is consistent with the conclusions from confocal microscopy, which indicated that Rab11a labels a unique membrane compartment distinct from the regulated secretory pathway in
LGACs.
pIgR and dIgA are sorted into the Rab11a-regulated transcytotic pathway
In fixed and non-permeabilized LGACs, pIgR at the basolateral plasma membrane is accessible to added antibody, whereas pIgR is not detectable intracellularly or at the apical plasma membrane (Fig. 4A) . Analysis of pIgR in fixed and permeabilized acini LGACs transduced with CellLight RFP-Rab5a Bacmam2.0 reagent were fixed, permeabilized and labeled with primary sheep anti-pIgR serum and secondary Alexa-Fluor-488-conjugated donkey antigoat antibody, as well as Alexa-Fluor-647-conjugated phalloidin. (C,D) LGACs expressing WT and DN EGFPRab11a were fixed, permeabilized, and labeled with primary sheep anti-pIgR serum and secondary Alexa-Fluor-568-conjugated donkey anti-sheep antibody, as well as Alexa-Fluor-647-conjugated phalloidin. *, lumen; scale bar: 5 mm.
LGACs expressing EGFP-Rab11a WT or DN were pulsed with 300 mg/ml biotin-dIgA for 15 minutes, with or without a 30-minute chase period, as described in Materials and Methods. The recovery of biotin-dIgA is shown as relative intensity. *P,0.05 (two-sample t-test).
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reveals basolateral membranes and also the intracellular membrane pools of pIgR. Some pIgR was detected in basolateral early endosomes labeled by RFP-Rab5a (Fig. 4B) . Overexpressed EGFP-Rab11a WT colocalized with pIgR in the subapical region of the cell (Fig. 4C ), similar to endogenous Rab11a (Fig. 1C) , indicating that some pIgR traffics into or through the Rab11a-enriched membrane compartment, perhaps en-route to the apical plasma membrane. Consistent with the concept that Rab11a mediates the traffic, overexpressed EGFPRab11a DN substantially reduced accumulation of pIgR in the subapical domain (Fig. 4D) .
On the basis of this observation, we hypothesized that dysfunction of Rab11a disrupts the Rab11a-regulated transcytotic pathway and results in intracellular accumulation of dIgA, the ligand of pIgR, prior to its release at the apical membrane. We used biotinylated rabbit dIgA as a tool to evaluate the function of Rab11a in transcytosis. Many lumena in reconstituted acini are open to the culture medium (Jerdeva et al., 2005) . Thus, biotinylated dIgA taken up by basolateral surface-exposed pIgR (Fig. 4A ) would be transcytosed to the apical membrane and released into the medium; whereas, if transcytosis were blocked, the biotinylated dIgA would be trapped inside the cells. After a 15-minute pulse with 300 mg/ml biotin-dIgA, LGACs expressing EGFP-Rab11a DN showed about 60% more accumulation of biotin-dIgA in cell lysates relative to those expressing EGFP-Rab11a WT; after an additional chase for 30 minutes, the LGACs expressing EGFPRab11a DN showed roughly equivalent biotin-dIgA inside the cell relative to the cells expressing EGFP-Rab11a WT (Fig. 4E ). These data suggest that dysfunction of Rab11a affects accumulation of biotin-dIgA, increasing the steady-state content as assessed at the end of the pulse-labeling step. During the subsequent chase period, it is possible that this accumulated biotin dIgA is degraded and/or recycled or, alternatively, is ultimately able to reach the apical plasma membrane for release in a process that is normally facilitated at a faster rate by Rab11a.
Trafficking of Rab11a-enriched vesicles involves the MT network
LGACs have a MT network that is organized in a polarized manner. Microtubule-organizing centers (MTOCs) labeled by ctubulin are located in the subapical region beneath the lumena. MTs radiating from the MTOCs are abundant; some are intertwined in the subapical domain, others extend their plusends to the basal cytoplasm (Fig. 5A,B) . Since MTOCs and subapical MTs are located in regions rich in subapical Rab11a, we hypothesized that EGFP-Rab11a-enriched vesicles are transported on MTs or that their localization is dependent upon MTs. To test this hypothesis, we treated LGACs with nocodazole, an agent that disrupts MTs. Nocodazole substantially reduced the number and length of MTs in LGACs, and caused EGFP-Rab11a-enriched vesicles to redistribute from the subapical to the basolateral domain (Fig. 5B,C) . The maintenance of the subapical pool of EGFPRab11a-enriched vesicles, therefore, appeared to be dependent on the integrity of the MT network.
In fixed LGACs, EGFP-Rab11a was also highly colocalized with p150 (Fig. 5B,C) , which is a subunit of the dynactin complex and a cytoplasmic dynein motor cofactor (Vaughan and Vallee, 1995; Wang et al., 2003; Kardon and Vale, 2009) . Although dispersed to the basolateral region after nocodazole treatment, EGFP-Rab11a retained its colocalization with p150. This result indicates that the interaction of the p150 with Rab11a does not depend on intact MTs, although the Rab11a-p150-enriched membranes probably requires MTs for the maintenance of the Rab11a-enriched compartment and/or Rab11a-enriched vesicle movement.
The trafficking of Rab11a-enriched vesicles associated with the F-actin network Although nocodazole altered the distribution of EGFP-Rab11a-enriched vesicles, live cell imaging showed that nocodazole did not inhibit all active movements of these vesicles (see Movie 5 in supplementary material). This result indicates that these vesicles use machinery for their trafficking in addition to MTs and their associated motors. Treatment with a combination of nocodazole and latrunculin B (a chemical which disrupts F-actin) inhibited essentially all movements of EGFP-Rab11a-enriched vesicles (see Movie 6 in supplementary material), suggesting that the motility of Rab11a-enriched vesicles depends on both the MT and the F-actin network.
Myosin motor head domains engage actin and are responsible for mechanochemical coupling of ATP hydrolysis to movement, whereas the tail domains interact with diverse cargoes. Overexpression of the tail domain saturates the tail-domainbinding sites on interacting effector proteins, preventing cargo from interacting with intact myosin motors. Owing to the sensitivity of a proportion of Rab11a-enriched vesicles to actin depolymerization and the relationship between Rab11a and myosin Vb demonstrated in other cells (Lapierre et al., 2001; Volpicelli et al., 2002; Fan et al., 2004; Wakabayashi et al., 2005; Provance et al., 2008; Gardner et al., 2011) , we hypothesized that expression of a myosin Vb tail construct alters the distribution or motility of Rab11a-enriched membranes in LGACs. When expressed alone, the mCherry-myosin Vb tail-enriched compartment was highly concentrated around the MTOCs in the subapical domain (Fig. 6A) . When mCherry-myosin Vb tail was co-expressed with EGFP-Rab11a, it completely colocalized with EGFP-Rab11a vesicles (Fig. 6B) , and also completely inhibited their dynamic movements in live cells ( Fig. 6C ; see Movie 7 in supplementary material). This result indicates that, apparently by competing with the endogenous myosin Vb motor, the mCherry-myosin Vb tail completely inhibits the dynamic movements of these vesicles. However, nocodazole partially dispersed the subapical pool of these immobile vesicles and induced their redistribution to the basolateral domain (Fig. 6B) . This confirms that Rab11a-enriched vesicles are associated with both the MT and the F-actin networks.
The expression of mCherry-myosin Vb tail also substantially altered the localization of p150. Confocal fluorescence microscopy revealed that p150 was highly concentrated in the subapical compartment labeled by mCherry-myosin Vb tail, whereas p150 was more evenly distributed in the subapical region of non-transduced cells (Fig. 7A, Fig. 5B) . Moreover, the compartment labeled by mCherry-myosin Vb tail was located in the periphery of the MTOCs labeled by c-tubulin in the subapical region. As mentioned above, EGFP-Rab11a completely colocalized with mCherry-myosin Vb tail. These findings suggest that myosin Vb and a MT-dependent motor, which uses the dynactin complex -probably cytoplasmic dynein, are both associated with Rab11a-enriched vesicles; these then accumulate around the MTOCs under the driving force of the MT-dependent motor when their association with the F-actin network is disrupted by the mCherry-myosin Vb tail.
Remarkably, overexpression of mCherry-myosin Vb caused pIgR and endocytosed dIgA to accumulate in the subapical compartment surrounding the MTOCs labeled by mCherrymyosin Vb tail (Fig. 1C, Fig. 7B,C,D) . This suggests that Rab11a, myosin Vb, the dynactin complex and pIgR are recruited into the same membrane compartment that regulates the transcytosis of dIgA, and the trafficking of this compartment involves both myosin Vb and the dynactin complex.
By contrast, overexpression of mCherry-myosin Vb did neither cause redistribution of YFP-Rab27b-enriched or Rab3D-enriched secretory vesicles (Fig. 7E, and supplementary material Fig. S2D ), nor did it alter the trafficking of YFP-Rab27b-enriched secretory vesicles at the resting stage or under CCh stimulation (see Movies 8-10 in supplementary material). These results show that the myosin Vb motor regulating the trafficking of Rab11a-enriched vesicles is clearly not involved in the regulated secretory pathway in the LGACs; thus, further supporting our conclusion that Rab11a labels a pathway distinct from the regulated secretory pathway.
Discussion
Many previous studies that aimed to identify the role of Rab11a in transcytotic and other trafficking pathways have used -as model systems -cells that do not normally transcytose or secrete the proteins under study. Rab11a was shown to participate in the exocytosis of transduced human growth hormone in bladder umbrella cells (Khandelwal et al., 2008) and in the basolateral-toapical transcytosis of dIgA mediated by exogenous pIgR in MDCK cells (Casanova et al., 1999; Wang et al., 2000) . These elegant cell biological studies have provided valuable insights into general trafficking mechanisms, and we wished to learn whether they are applicable to transcytotic trafficking of pIgR and dIgA in a primary acinar cell that is responsible for mucosal defense and engages robustly in both constitutive transcytosis and regulated apical exocytosis. LGACs expressing EGFP-Rab11a were incubated on ice for 5 minutes, and then incubated at 37˚C without or with 33 mM nocodazole for 2 hours. The cells were fixed, permeabilized and labeled with primary mouse anti-a-tubulin (B), antip150 antibodies (C) and secondary AlexaFluor-568-conjugated goat anti-mouse antibody, as well as Alexa-Fluor-647-conjugated phalloidin. *, lumen; scale bar: 5 mm; Con, Control, Noc: Nocodazole. Arrows show regions of colocalization of p150 and EGFP-Rab11a before and after nocodazoleinduced dispersal of the Rab11a-enriched compartment.
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Confocal fluorescence microscopy analysis has confirmed that Rab11a associates with membranes enriched in pIgR and dIgA. Intriguingly, access of Rab11a-enriched membranes to endocytosed materials seems to be cargo-specific because TMR-dextran, a fluid phase marker, showed no ability to accumulate in compartments enriched in Rab11a. Expression of GDP-locked Rab11a DN caused redistribution of pIgR to basolateral compartments while inhibiting the transcytosis of dIgA, which suggests that the function of Rab11a in the basolateral-to-apical transcytosis requires cycling of Rab11a between its GTP-bound and GDP-bound forms.
We also characterized the association between Rab11a-enriched vesicles and the cytoskeleton. Localization and trafficking of Rab11a vesicles is dependent on both the MT and the F-actin networks, and regulated by a minus-end-directed MT-based motor using the dynactin complex and by myosin Vb, respectively. Our study characterized the actin-and MTdependent trafficking mechanisms of Rab11a-enriched vesicles in the constitutive physiological transcytotic pathway regulated by Rab11a. Our data suggest that a minus-end-directed MT-based motor using the dynactin complex, and myosin Vb are both recruited onto Rab11a-enriched vesicles. The sorting of dIgA and/or pIgR into the Rab11a compartment is, however, independent of myosin Vb, because in LGACs that overexpress mCherry-myosin Vb tail, the pIgR or endocytosed dIgA still accumulates in the compartment labeled by myosin Vb tail and Rab11a (Fig. 7B,D) .
Myosin Vc has previously been demonstrated to be a crucial regulator of actin filament remodeling implicated in mature secretory vesicle exocytosis in LGACs (Marchelletta et al., 2008) . Our previous work has also shown that Rab27b-enriched secretory vesicles in LGACs are associated with the myosin Vc motor (Chiang et al., 2011) . These previous data revealed that the expression of mCherry-myosin Vb tail did not alter the regulated secretory pathway labeled by YFP-Rab27b or Rab3D in LGACs, whereas it induced substantial relocation and complete trafficking inhibition of EGFP-Rab11a-enriched vesicles. This clearly indicates the differentiation in the functions of myosin V motor isoforms in specialized secretory epithelial cells that express all three class V myosin motor isoforms (Marchelletta et al., 2008) , and further demonstrates that Rab11a regulates a pathway distinct from the regulated secretory pathway in exocrine acinar cells.
Rab11a participates in regulated exocytosis in other specialized epithelial cells, such as urinary bladder umbrella cells (Khandelwal et al., 2008) and HCl-secreting gastric parietal cells (Duman et al., 1999) . In bladder umbrella cells and gastric parietal cells, regulated exocytosis of membrane vesicles with the apical membrane functions to increase apical membrane surface area and the number of membrane transporters at the apical membrane, respectively; and this process is inhibited by expression of Rab11a DN. However, using LGACs, our data from confocal fluorescence microscopy and biochemical analysis of protein and b-hexosamindase secretion clearly showed that acinar cells do not rely upon Rab11a to drive regulated secretory vesicle exocytosis, because expression of EGFP-Rab11a DN does not inhibit these secretory activities. Thus, it is possible that the role of Rab11a in regulated exocytosis within bladder umbrella and gastric parietal cells, but not acinar cells, reflects the very different functions of secretory vesicles in these epithelial cells.
On the basis of these observations, we propose a model for the transcytosis of pIgR and dIgA in LGACs (Fig. 8) . Basolaterally endocytosed pIgR and dIgA first enter Rab5a-labeled early endosomes. Thereafter, they are sorted into Rab11a-enriched vesicles, which are transported on MTs, towards the apical region, where they form a subapical pool for the further release of sIgA into the lumen. We propose, owing to the enrichment of the p150 cofactor of the dynactin complex with Rab11a, combined with the known polarity of MTs in LGACs with minus-ends apical (da Costa et al., 1998) , that the cytoplasmic dynein motor is responsible for driving Rab11a-enriched vesicles towards 
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LGACs co-expressing YFP-Rab27b and mCherrymyosin Vb tail were imaged by confocal fluorescence microscopy. Cellular outlines were obtained by comparing the respective image with the DIC image. *, lumena; scale bar: 5 mm.
subapical MTOCs. During the process of basolateral-to-apical transport, the Rab11a-enriched vesicles experience a motorswitch step by recruiting myosin Vb, which regulates the movement of these vesicles on the cortical F-actin network towards the apical plasma membrane. The trafficking mechanism of Rab11a-enriched vesicles based on the coordination of MTbased and F-actin-based motors in our model is consistent with other proposed coordination between MT-based and actin-based motors that facilitate transport processes such as regulated exocytosis of secretory granules in melanocytes (Barral and Seabra, 2004; Ross et al., 2008 ). In our model, Rab11a-enriched subapical vesicle dissociation from the MT network should, in the presence of active myosin Vb motor, result in their redistribution to subapical F-actin; whereas their dissociation from the actin network in acini that express the mCherry-myosin Vb-tail should, in the presence of active cytoplasmic dynein, cause these vesicles to accumulate on MTs and at the MTOC. These assumptions are consistent with our observations described here (Fig. 5C, Fig. 7A ).
Rab11a is known to participate in the apical recycling of dIgA in MDCK cells that express pIgR (Casanova et al., 1999) . Therefore, it is reasonable to hypothesize that Rab11a also participates in the apical recycling of specific cargoes in LGACs, which are -like MDCK cells -polarized epithelial cells. The subapical pool of Rab11a vesicles might represent a compartment engaged both in basolateral-to-apical transcytosis as well as apical recycling.
In summary, we show here that Rab11a labels a cargo-specific membrane compartment that participates in the transcytosis of pIgR and/or dIgA in LGACs, polarized epithelial cells specialized physiologically for transcytosis and apical exocytosis. This compartment is distinct from the lysosomal pathway and the secretory pathway. We propose that the trafficking of the Rab11a-enriched vesicles occurs in association with the MT and the F-actin networks, regulated by cytoplasmic dynein and myosin Vb, respectively.
Materials and Methods
Reagents
Carbachol (CCh) was purchased from Sigma-Aldrich (St Louis, MO). Pepstatin A, tosyl phenylalanyl chloromethyl ketone, leupeptin, tosyl lysyl chloromethyl ketone, soybean trypsin inhibitor, and phenylmethane sulphanyl fluoride were also purchased from Sigma-Aldrich and were used in the protease inhibitor cocktail for preparation of cellular homogenates as previously described (Vilalta et al., 1998) . Alexa-Fluor-488-conjugated goat anti-mouse, FITC-conjugated goat anti-mouse, Alexa-Fluor-568-conjugated donkey anti-sheep, and Alexa-568-conjugated goat anti-mouse secondary antibodies, Alexa-647-conjugated phalloidin, Tetramethylrhodamine (TMR)-dextran (MW 70,000), Lysotracker Red DND-99 and Prolong anti-fade Kit were purchased from Molecular Probes/Invitrogen (Carlsbad, CA). Rabbit anti-Rab11a serum was a kind gift from James Goldenring (Vanderbilt University Medical Center, Nashville, TN). Mouse anti-Rab11 antibody and mouse anti-c-adaptin antibody were purchased from BD Biosciences (San Jose, CA). Mouse anti-green fluorescent protein (GFP) antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-Rab3D serum was raised against recombinant Rab3D expressed in bacteria as previously described (Evans et al., 2008) . Sheep anti-serum that recognizes the extracellular domain of pIgR was prepared by Caprilogics (Hardwick, MA) using SC from rabbit gall bladder bile as antigen. IRDye800-conjugated and IRDye700-conjugated donkey anti-goat and goat anti-mouse secondary antibodies, as well as IRDye800-conjugated streptavidin, were purchased from Rockland (Gilbertsville, PA). Blocking buffer was purchased from Li-COR Biosciences (Lincoln, NB). CellLight RFP-Rab5a Bacmam2.0 reagent was purchased from Molecular Probes/Invitrogen (Carlsbad, CA). EZ-Link Sulfo-NHS-Biotin was purchased from Pierce/Thermo Scientific (Rockford, FL). Doxycycline was obtained from Clontech (Mountain View, CA). Peter's complete medium (PCM) was prepared by mixing Ham's F-12 (from Thermo Scientific) and DMEM with 1.5 g/l glucose (Mediatech, Manassas, VA) at a 1:1 ratio and adding other reagents to the following final concentrations: penicillin 100 U/ml, streptomycin 0.1 mg/ml, linoleic acid 0.3 mM, n-butyric acid 2 mM, transferrin 5 mg/ml, insulin 5 mg/ml, sodium selenite 30 nM, hydrocortisone 5 nM, laminin 4 mg/ml, CCh 0.1 mM/ml and L-thyroxine 1 nM. Matrigel was from BD Biosciences. All other reagents were the highest quality available.
Preparation of primary LGAC and treatment conditions
Female New Zealand White rabbits (1.8-2.2 kg) were obtained from Irish Farms (Norco, CA). Isolation of LGACs was in accordance with previously established protocol (Rismondo et al., 1994) .
LGACs cultured for 2-3 days in PCM aggregate into acinus-like structures (Fig. 1B) while individual cells within these structures display distinct apical and basolateral domains and maintain secretory responses to CCh (Evans et al., 2008) . Experimental treatments were as follows: CCh, 100 mM for 15 minutes; nocodazole, 33 mM on ice for 5 minutes, and then at 37˚C for 2 hours; latrunculin B, 10 mM for 30 minutes; nocodazole plus latrunculin B, similar to nocodazole treatment, except for that latrunculin B was added into the media to reach a working concentration of 10 mM at 1.5-hour of 37˚C incubation. LGACs. pIgR with or without bound dIgA is endocytosed and transported into Rab5a-labeled early endosomes, and then sorted into Rab11a-enriched vesicles. These are then transported on microtubules towards the minus ends anchored on MTOCs located in the subapical region by cytoplasmic dynein. During the process of basolateral-to-apical transport, Rab11a-enriched vesicles recruit myosin Vb, which enables their movement on the subapical F-actin network. When Rab11a-enriched vesicles that contain pIgR and dIgA are released at the apical surface, the extracellular domain of the pIgR bound to dIgA is proteolytically cleaved, and sIgA is released into mucosal secretions. APM, apical membrane; BLM, basal membrane; SC, secretory component; dIgA, dimeric IgA; sIgA, secretory IgA; MT, microtubule; MTOC, microtubule-organizing center.
Production and purification of adenovirus constructs
Human Rab11a WT and dominant-negative S25N mutant Rab11a (Rab11a DN) in the pEGFP-C2 plasmid, as well as the plasmid mCherry-C1-MyoVb-tail-DD encoding rabbit myosin Vb tail fused to mCherry were kind gifts from James Goldenring, Vanderbilt University (Fan et al., 2004) . In these plasmids, EGFP was fused to the N terminus of human Rab11a, whose protein sequence is identical to rabbit Rab11a. The dominant-negative variant maintains a GDP-locked conformation. The pEGFP-C2 Rab11a WT was digested with Nhel and Sall restriction enzymes at the 592 bp (59 end) and the 2046 bp (39 end) site of the pEGFP-C2 Rab11a WT vector, respectively. The pEGFP-C2 Rab11a WT was digested with Nhel and Eagl restriction enzymes at the 592 bp (59 end) and the 1334 bp (39 end) site of the pEGFP-C2 Rab11a WT vector, respectively. The pEGFP-C2 Rab11a S25N was digested with Nhel and Sall restriction enzymes at the 592 bp (59 end) and the 2046 bp (39 end) site of the pEGFP-C2 Rab11a S25N vector, respectively. The 1454-bp fragment encoding EGFP-Rab11a WT, the 742-bp fragment encoding EGFP and the 1454-bp fragment encoding EGFP-Rab11a S25N were subcloned into the pTRE-Shuttle2 vector from the AdenoX Tet-on expression system kit (Clontech, Mountain View, CA) and further subcloned into the AdenoX System 1 viral DNA vector, respectively. The recombinant viral DNA vectors were linearized with PacI restriction enzyme and used to transfect the HEK-293-derived helper cell line QBI-HEK 293A in accordance to the manufacturer's protocol (Clontech; Adeno-X Tet-Off and Tet-On Expression System 1; cat. numbers 631022 and 631050.). Ad EGFP-Rab11a WT, Ad EGFP and Ad EGFP-Rab11a DN (S25N) all require co-transduction with the Adeno-X Tet-On regulatory virus and induction with doxycycline for protein expression. To generate the adenoviral construct for myosin Vb tail, the entire open reading frame for mCherry-myosin Vb tail was PCR amplified using the following primer pairs: sense primer, 59-taaaggccttaccgccatgcattag-39; antisense primer, 59-tttaggcctaccacaactagaatgc-39. The PCR product was digested with StuI, subcloned into pDC311 and further subcloned into viral DNA vector from AdMax expression system (Microbix Biosystems Inc., Canada). YFP-Rab27b was a kind gift from Serhan Karvar (Division of Gastrointestinal & Liver Diseases, University of Southern California, Los Angeles, CA). All Ad vectors were amplified in QBI cells according to established protocols (Wang et al., 2003) .
Adenovirus transduction
LGACs were transduced on the secondday of culture.
LGACs seeded in culture dishes were co-incubated for 2 hours at 37˚C with each of the Ad EGFP-Rab11a constructs and the Adeno-X Tet-On regulatory virus, at a multiplicity of infection (MOI) of 5 for each virus. The Adeno-X Tet-On regulatory virus encodes a regulatory protein that recognizes the reverse Tet repressor (rTetR) in our constructs and, therefore, induces the expression of recombinant proteins in
LGACs. Doxycycline was added at a concentration of 1 mg/ml after the removal of virus and replacement of culture medium. Ad mCherry-myosin Vb tail and Ad YFP-Rab27b were used alone at an MOI of 5 for 2 hours of incubation at 37˚C for transduction. However, when Ad mCherry-myosin Vb tail or Ad YFP-Rab27b was used for co-transduction with the doxycyline-inducible constructs, the regulatory virus and doxycycline were also applied. After virus transduction, LGACs were cultured another 16-18 hours before analysis.
For membrane isolation or biotin-dIgA uptake assays, LGACs on the second day of culture were collected by centrifugation at 50 g for 5 minutes and resuspended in culture medium at a density of 1.7610 7 cells/ml.
LGACs were co-incubated for 2 hours at 37˚C with the Ad EGFP-Rab11a WT or DN constructs and with the Adeno-X Tet-On regulatory virus, at a multiplicity of infection (MOI) of 5 for each virus, respectively. Then the cells were washed with fresh medium, and reseeded in culture dishes at 5.4610 6 cells/ml in fresh medium. The cells were cultured with doxycycline as described above for another 16-18 hours before use.
Baculovirus Transduction
Culture medium from LGACs on the second day of culture was aspirated, and fresh medium containing CellLight RFP-Rab5a Bacmam 2.0 reagent was added to reach a final concentration of 30 particles per cell, as suggested by the manufacturer's protocol. The cells were gently shaken at 37˚C for 1 hour to maximize transduction efficiency, and then cultured for another 16-18 hour before analysis.
Cell fractionation Approximately 1.60610 8 LGACs were homogenized with a Dounce tissue homogenizer for 20 cycles in 2 ml homogenization buffer (250 mM sucrose, 1 mM EDTA, 3 mM imidazole, pH 7.4) with protease inhibitor cocktail (1 mM PMSF, 1.75 mg/ml aprotinin, 2.5 mg/ml soybean trypsin inhibitor, 1 mg/ml chymostatin, 1 mg/ml pepstatin A, 1 mg/ml leupeptin). The homogenate was centrifuged at 800 g for 10 minutes. The post-nuclear supernatant (PNS) was centrifuged in a Sorvall RC M120EX ultracentrifuge (Thermo Scientific, Rockford, FL) at 15,000 rpm for 1 hour. Supernatant (Si) and pellet (Pi) resuspended in homogenization buffer were analyzed by western blotting.
Quantification of secretion
LGACs grown on Matrigel-coated 12-well plates were transduced or not on the second day of culture and treated on the third day of culture. The culture supernatant was extracted after treatment for quantification of secretion. The secretion of b-hexosaminidase was quantified using previously established method (Andersson et al., 2006) . The total protein secretion was quantified by the Bio-Rad protein assay. Cell pellets in the plates were dissolved with 0.5 M NaOH and quantified by the BCA protein assay for normalizing the secretion of b-hexosaminidase and bulk protein to protein in the cell pellet.
Generation of rabbit B-cell hybridomas for dIgA production and purification of dIgA
The lacrimal gland from three female New Zealand White rabbits (weighing ,4 kg) from Irish Farms (Norco, CA) were collected, minced and digested to isolate the interstitial cells as in previously established methods (Guo et al., 2000) . Interstitial cells were frozen and sent to Epitomics Inc. (Burlingame, CA) for fusion with a proprietary rabbit myeloma cell line. The three hybridoma multiclones with the highest dIgA yields were selected by ELISA. The coating and detection antibody used for analysis were goat Anti-Rabbit IgA and HRPconjugated goat Anti-Rabbit IgG, respectively, both from Abcam (Cambridge, MA). Each multi-clone was further expanded to 12 subclones, from which nine subclones with the highest dIgA yields were selected. The rabbit dIgA produced by clone 13-9 was used in this study (supplementary material Fig. S4 ).
Clone 13-9 hybridoma cells were cultured in RPMI 1640 medium, with cell density maintained between 1610 5 and 1610 6 cells/ml. The culture supernatant was concentrated by centrifugation at 3000 g with 100 kDa centrifugal filter (Millipore, Billerica, MA), filtered through a 0.2 mm filter, and then loaded into a PBS-equilibrated HiPrep 16/60 Sephacryl S-300 HR column (GE Healthcare, Piscataway, NJ) installed on a DuoFlow chromatography system (Bio-Rad, Hercules, CA) via a 5 ml injection loop. dIgA was eluted with PBS at a flow rate of 1 ml/min and monitored by UV absorbance at 280 nm. Fractions containing dIgA were pooled and concentrated by centrifugation at 3000 g with 100 kDa centrifugal filter. The purity of dIgA was determined by SDS-PAGE, and the concentration of dIgA was measured using a NanoDrop Spectrophotometer (NanoDrop products, Wilmington, DE).
Uptake and accumulation of dIgA
Purified dIgA was incubated with a tenfold excess of EZ-Link Sulfo-NHS-Biotin reagent at room temperature for 30 minutes, in accordance with the manufacturer's protocol. Excessive reagent was removed by dialysis in PBS at 4˚C overnight. For each treatment condition, 2.88610 8 LGACs on the third day of culture were resuspended in 1 ml binding medium (PCM containing 20 mM HEPES, 2 mM CaCl 2 , 2 mM MgCl 2 and 3% (m/v) BSA), and incubated with 300 mg/ml biotindIgA at 37˚C with shaking for 15 minutes. The cells were washed with ice-cold PCM, and then incubated with/without an additional 30-minute chase in binding medium at 37˚C. Cells were then washed with ice-cold PCM, resuspended with 1 ml Ham's buffer containing 0.04 mg trypsin, and incubated on ice with shaking for 1 hour to remove biotin-dIgA from the cell surface. Cells were again washed with ice-cold Ham's buffer, and then lysed with 0.1% Triton X-100 dissolved in PBS containing the protease inhibitor cocktail. The lysates were centrifuged at 10,000 g for 10 minutes to remove cell debris, and the protein concentrations of the supernatant were determined with the Bio-Rad Protein Assay Kit according to the manufacturer's protocol. Aliquots of each cell lysate containing 100 mg of protein were mixed with non-reducing SDS-PAGE loading buffer and electrophoresed on 6% acrylamide gels under non-reducing conditions. Western blot membranes were probed with IRDye800-conjugated Streptavidin, scanned using an Odyssey Imaging System from LI-COR, and biotin-dIgA was quantified with the Odyssey 1.1 software. The relative recovery of biotin-dIgA in each treatment group was calculated as the biotin-dIgA signal strength divided by the biotin-dIgA signal of the 15-minute pulse group.
Confocal microscopy and image processing
Images were taken with a Zeiss LSM 510 Meta inverted confocal microscope equipped with Argon, red HeNe, and green HeNe lasers, using a 636 oil immersion objective lens with a NA of 1.4. For construction of 3D models of LGACs, images taken from consecutive confocal planes at 0.4 mm intervals were projected at the Y-axis using Zeiss LSM image examiner. For live cell imaging,
LGACs were cultured on 35 mm glass coverslip-bottomed dishes (MatTek, Ashland, MA) coated with Matrigel for 2 days, and transduced with Ad constructs as detailed above. On the third day of culture, the cells were mounted and imaged in a 37˚C incubation chamber. For analysis of intracellular organelle movements in live cells (supplementary material Movies 1-10), images from a single confocal plane were taken sequentially at a fixed time interval of 10 seconds. For TMRdextran uptake experiments, LGACs expressing EGFP-Rab11a were incubated with 2 mg/ml TMR-dextran in PCM for 1 hour. The cells were then washed with fresh medium three times before microscopic imaging. For labeling lysosomes,
LGACs were incubated with 50 nM Lysotracker Red DND-99 in PCM 1 hour before observation.
Indirect immunofluorescence
After treatments, LGACs cultured on Matrigel-coated glass coverslips were fixed with 4% paraformaldehyde in PBS for 15 minutes, incubated with 50 mM NH 4 Cl in PBS for 5 minutes, and then permeabilized with 0.1% Triton X-100 in PBS for 10 minutes. After washing with PBS thoroughly, cells were blocked with 1% BSA in PBS overnight at 4˚C.
LGACs were then incubated with the appropriate primary, fluorophore-conjugated primary and secondary antibodies and AlexaFluor-647-conjugated phalloidin.
